Showing 1 - 10 of 247
Rationale Increasing attention is being given to the evaluation of public health interventions. Methods for the economic evaluation of clinical interventions are well established. In contrast, the economic evaluation of public health interventions raises additional methodological challenges. The...
Persistent link: https://www.econbiz.de/10008483573
Persistent link: https://www.econbiz.de/10007252699
Persistent link: https://www.econbiz.de/10000964453
Persistent link: https://www.econbiz.de/10011781159
Persistent link: https://www.econbiz.de/10007248097
The National Institute for Health and Clinical Excellence (NICE) invited the manufacturer of trastuzumab, Roche Pharmaceuticals, to submit evidence for the clinical and cost effectiveness of this drug for the treatment of advanced gastric cancer (aGC), as part of the Institute’s single...
Persistent link: https://www.econbiz.de/10010848963
Persistent link: https://www.econbiz.de/10009404157
Persistent link: https://www.econbiz.de/10007244090
Persistent link: https://www.econbiz.de/10007247520
Persistent link: https://www.econbiz.de/10007253192